A Study of Nivolumab and Ipilimumab Combined With Chemotherapy Compared to Chemotherapy Alone in First Line NSCLC
Clinical trial NCT03215706 · COMPLETED
Trial details
- NCT number
- NCT03215706
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-24
- Primary completion
- 2019-08-16
- Enrollment
- 719
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.